Bonus: Jeremy Levin

FromFirst Rounders

Start listening View podcast show

Bonus: Jeremy Levin

FromFirst Rounders

ratings:

Length:

46 minutes

Released:

Apr 22, 2020

Format:

Podcast episode

Description

A conversation with Jeremy Levin, chairman of the Biotechnology Innovation Organization and CEO of Ovid Therapeutics, about industry versus government responses to covid19, the split within biotech on how to address charges of high prices, and why the biopharma industry is so disliked. Hosted on Acast. See acast.com/privacy for more information.

Released:

Apr 22, 2020

Format:

Podcast episode

Titles in the series (61)

Nature Biotechnology's First Rounders podcast is a series of conversations with founders, financers and developers from biotech's past, present and future. Hosted on Acast. See acast.com/privacy for more information.

Skip carousel

First Rounder: Henri Termeer: Nature Biotechnology podcast by First Rounders
42 min listen
First Rounder: George Yancopoulos: Nature Biotechnology podcast by First Rounders
57 min listen
First Rounder: James Wilson: Nature Biotechnology podcast by First Rounders
66 min listen
First Rounder: Daphne Zohar: Nature Biotechnology podcast by First Rounders
49 min listen
First Rounder: Colin Goddard: Nature Biotechnology podcast by First Rounders
58 min listen
First Rounders: Michael West: Nature Biotechnology podcast by First Rounders
57 min listen
First Rounder: William A. Haseltine: Nature Biotechnology podcast by First Rounders
51 min listen
First Rounder: Julian Davies: Nature Biotechnology podcast by First Rounders
56 min listen
First Rounder: Una Ryan: Nature Biotechnology podcast by First Rounders
52 min listen
First Rounders: Harvey Berger: Nature Biotechnology podcast by First Rounders
53 min listen
First Rounder: Carl Feldbaum: Nature Biotechnology podcast by First Rounders
68 min listen
First Rounder: Stan Crooke: Nature Biotechnology podcast by First Rounders
65 min listen
First Rounder: Mary Tanner: Nature Biotechnology podcast by First Rounders
57 min listen
First Rounder: Kari Stefansson: Nature Biotechnology podcast by First Rounders
55 min listen
First Rounder: Focus issue podcast: Nature Biotechnology podcast by First Rounders
40 min listen
First Rounder: Leroy Hood: Nature Biotechnology podcast by First Rounders
55 min listen
First Rounder: David Baltimore: Nature Biotechnology focus issue podcast by First Rounders
66 min listen
First Rounder: Nancy J Kelley: First Rounder: Nancy J Kelley by First Rounders
66 min listen
First Rounder: Tom Maniatis: Nature Biotechnology podcast by First Rounders
78 min listen
First Rounder: Anu Acharya: First Rounder: Anu Acharya by First Rounders
68 min listen
First Rounder: Rachel King: Nature Biotechnology podcast by First Rounders
58 min listen
First Rounder: Bill Rutter: Nature Biotechnology podcast by First Rounders
53 min listen
First Rounder: Jan Vilcek: Nature Biotechnology podcast by First Rounders
65 min listen
First Rounder: Jeremy Levin: First Rounder: Jeremy Levin by First Rounders
95 min listen
First Rounder: Rachel Haurwitz: Nature Biotechnology podcast by First Rounders
44 min listen
First Rounder: Daniel Cohen: Nature Biotechnology podcast by First Rounders
61 min listen
First Rounders: Christoph Lengauer: Nature Biotechnology podcast by First Rounders
77 min listen
First Rounder: Greg Winter: Nature Biotechnology podcast by First Rounders
82 min listen
First Rounders: Robert Langer: Nature Biotechnology podcast by First Rounders
64 min listen
First Rounder: Jeff Leiden: Nature Biotechnology podcast by First Rounders
70 min listen

More Episodes from First Rounders

Skip carousel

Good Bye by First Rounders
4 min listen
Jay Keasling by First Rounders
72 min listen
Ingmar Hoerr by First Rounders
63 min listen
Lita Nelsen: Lita Nelsen is the former long-time director of the Technology Licensing Office at the Massachusetts Institute of Technology. Her talk with Nature Biotechnology covers her father’s life designing television antennas, what drove her to the chemical engi... by First Rounders
52 min listen
Hope Lies in Dreams Chapter 1: Stan Crooke is born ⬩ A tenuous existence ⬩ Life with his mother ⬩ The Tech Corner ⬩ Arsenal Tech High School ⬩ Nancy ⬩ Hoodlum ways ⬩ Off to Purdue by First Rounders
34 min listen
Anthony Atala: Anthony Atala is the director of the Institute for Regenerative Medicine at Wake Forest University. He is also a co-founder of Precise Bio. His conversation with Nature Biotechnology covers implanting the first tissue-engineered bladder into a patient,... by First Rounders
66 min listen
Nancy Simonian: Nancy Simonian is president and CEO of Syros Pharmaceuticals. Her conversation with Nature Biotechnology covers going against the advice of her mentor to take a job at Biogen; the long, winding path to approval for the multiple myeloma drug Velcade; an... by First Rounders
68 min listen
Carl June: Carl June is a co-founder of Tmunity Therapeutics, and a professor in immunotherapy at the University of Pennsylvania, where he also runs the June Lab. His conversation with Nature Biotechnology includes how a boyhood fractured arm led him to his first... by First Rounders
65 min listen
$Carl June: Carl June is a co-founder of Tmunity Therapeutics, and a professor in immunotherapy at the University of Pennsylvania, where he also runs the June Lab. His conversation with Nature Biotechnology includes how a boyhood fractured arm led him to his first...$
Craig Mello: Craig Mello is co-founder of Atalanta Therapeutics and a professor at the University of Massachusetts Medical School, where he runs the Mello Lab. He is also a Nobel Laureate. His conversation with Nature Biotechnology covers the lure of conspiracy the... by First Rounders
72 min listen
Neil Kumar by First Rounders
61 min listen
Grace Colón: Grace Colón is president and CEO of InCarda Therapeutics. Her conversation with Nature Biotechnology covers growing up in San Juan, Puerto Rico; her love of musical theater; and how grad school at MIT guided her toward a career in entrepreneurship.... by First Rounders
64 min listen
Tillman Gerngross: Tillman Gerngross is the CEO and co-founder of Adimab, and a professor of bioengineering at Dartmouth College. His conversation with Nature Biotechnology covers his years at GlycoFi, the nature of problem solving in entrepreneurship, and Adimab’s paper... by First Rounders
72 min listen
Noubar Afeyan: Noubar Afeyan is the founder and CEO of Flagship Pioneering. His conversation with Nature Biotechnology covers his family fleeing the Lebanese Civil War when he was a boy, how a chance encounter at a scientific meeting opened his mind to entrepreneuris... by First Rounders
68 min listen
Katrine Bosley: Katrine Bosley is former CEO of Editas Medicines and Avila Therapeutics. She discusses growing up in Ohio, her first job in biotech (as an administrative assistant) and why her five years at CRISPR company Editas felt more like 1,000. This epi... by First Rounders
69 min listen
Ted Love: Ted Love is the president and CEO of Global Blood Therapeutics. In his conversation with Nature Biotechnology, he discusses why his time at Haverford College was transformative, why he views Global Blood Therapeutics as a social justice company, and wh... by First Rounders
82 min listen
Alexis Borisy: Alexis Borisy is CEO and Chairman of EQRx, and a long-time biotech builder with Third Rock Ventures. His conversation with Nature Biotechnology covers growing up as a “faculty brat” in Wisconsin, dropping out of his PhD program at Harvard and why, even... by First Rounders
66 min listen
Bassil Dahiyat by First Rounders
64 min listen
Forum: Schneeberger on Clavien: Senior Editor Irene Jarchum talks to Stefan Schneeberger about the significance of a recent Nature Biotechnology paper describing a sophisticated perfusion machine to keep human livers alive for a week. The work was carried out by Pierre-Alain Clavien ... by First Rounders
22 min listen
Greg Verdine: Greg Verdine is a professor at Harvard University, and CEO and president of FogPharma and LifeMine Therapeutics. He is co-founder of more than 10 companies. His talk with Nature Biotechnology covers growing up in the Pine Barrens of New Jersey, the imp... by First Rounders
73 min listen
First Rounders: Samantha Du: Nature Biotechnology podcast by First Rounders
68 min listen
First Rounders: Pardis Sabeti: Nature Biotechnology podcast by First Rounders
71 min listen
First Rounders: Nina Tandon: Nature Biotechnology podcast by First Rounders
66 min listen
First Rounders: Cigall Kadoch: Nature Biotechnology podcast by First Rounders
76 min listen
First Rounders: Robert Langer: Nature Biotechnology podcast by First Rounders
64 min listen
First Rounders: George Church: Nature Biotechnology podcast by First Rounders
68 min listen
First Rounders: Chad Womack: Nature Biotechnology podcast by First Rounders
64 min listen
First Rounders: Christoph Lengauer: Nature Biotechnology podcast by First Rounders
77 min listen
First rounders: Feng Zhang by First Rounders
66 min listen
First Rounder: John Maraganore: Nature Biotechnology podcast by First Rounders
64 min listen
First Rounder: Jeff Leiden: Nature Biotechnology podcast by First Rounders
70 min listen

Related podcast episodes

Skip carousel

Should The U.S. Have An Industrial Policy?: Presented by Rosemary Coates, Founder and Executive Director of The Reshoring Institute by Manufacturing Talk Radio
36 min listen
How Biotechs Survive the Valley of Death: For biotech companies, the valley of death describes the difficult path from initial discovery to FDA approval and commercialization. It's a treacherous journey—one that even promising innovations often don't complete. Adequate funding, regulatory hurdles and the immense complexity of the biotech landscape are among the never-ending challenges faced by early stage biotechs. In this episode we talk with two biotech executives about what it’s like to struggle and survive in this rough-and-tumble industry. by I AM BIO
25 min listen
Episode 97 by Biotech Hangout
61 min listen
What's Next For COVID Vaccines With Tonix Pharmaceuticals' Seth Lederman, M.D. by Business Of Biotech
67 min listen
Industry Calls for New Incentives to Spur Development of New Antibiotics: As concerns grow about the rise of antibiotic resistant bugs, the ability to combat them is being undermined by the economics of antibiotic drug development. Many large pharmaceutical companies stepped away from the space and despite the passage of t... by The Bio Report
22 min listen
How Biotechs Survive the Valley of Death (REDUX): For biotech companies, the valley of death describes the difficult path from initial discovery to FDA approval and commercialization. It's a treacherous journey—one that even promising innovations often don't complete. Adequate funding, regulatory hurdles and the immense complexity of the biotech landscape are among the never-ending challenges faced by early stage biotechs. In this episode we talk with two biotech executives about what it’s like to struggle and survive in this rough-and-tumble industry. by I AM BIO
25 min listen
July 15th, 2022 by The Top Line
30 min listen
The unintended consequences of small molecules by BioSpace
25 min listen
UK's NHS Backs World's Costliest Drug for Treatment of MLD + Report Finds Increase in Pharma Cybersecurity Threats by Xtalks Life Science Podcast
26 min listen
Bio & The Business Of Aging with Life Biosciences' Jerry McLaughlin by Business Of Biotech
65 min listen
Bringing new medicines to market despite subjective endpoints by Conversations in Healthcare
32 min listen
Ep 853 | All Your Questions About the Vaccine Answered? | Guest: Dr. Ryan Cole by Conservative Review with Daniel Horowitz
59 min listen
To know COVID-19 is to know medicine by Conversations in Healthcare
41 min listen
Arms within reach: Israel's vaccination lead: Aggressive purchasing, solid logistics and a competitive health-care system have led to a world-beating rate of immunisation—but, as ever, politics is playing a role, too. Big oil had a terrible 2020, but the sector’s troubles pre-date the pandemic; we... by The Intelligence from The Economist
23 min listen
Arms within reach: Israel's vaccination lead: Aggressive purchasing, solid logistics and a competitive health-care system have led to a world-beating rate of immunisation—but, as ever, politics is playing a role, too. Big oil had a terrible 2020, but the sector’s troubles pre-date the pandemic; we... by Economist Podcasts
23 min listen
Vaccine development needs new incentives (with Tahir Amin) by Pitchfork Economics with Nick Hanauer
27 min listen
Big Pharma’s Deadly Covid Vaccine Monopoly: A week ago, the Biden administration announced support for waiving intellectual property protection for Covid-19 vaccines. In response, Bio, a trade association representing biotechnology companies, issued a statement saying, "The United ... by Intercepted
32 min listen
The Latest on Antibiotic Development, Back Bay Life Science Advisors with Antabio by Back Bay Life Science Report
22 min listen
Episode 48 by Biotech Hangout
59 min listen
HOW YOU CAN PROTECT YOURSELF AGAINST MEDICAL BANKRUPTCY—Robert & Kim Kiyosaki featuring Robin Feldman: The leading cause of bankruptcy in the U.S. is from medical costs. Big Pharma is front-and-center to this problem. Robin Feldman joins Robert & Kim to discuss her research into how Big Pharma oftentimes secretly works to keep drug prices high and... by Rich Dad Radio Show: In-Your-Face Advice on Investing, Personal Finance, & Starting a Business
44 min listen
Merck’s new COVID-19 pill will save lives, but at what price? by The BioWorld Insider Podcast
28 min listen
Realizing the patient-friendly future of clinical trials by Conversations in Healthcare
23 min listen
EMF’s | An Emerging Health Crisis: The internet has connected humanity in unprecedented ways, allowing us to grow together and learn faster than ever before. However, this new age is not without old risks. Hay House CEO Reid Tracy interviews leading natural health... by You Can Heal Your Life ™
28 min listen
ML-Enabled Drug Discovery With LabGenius' James Field, Ph.D. by Business Of Biotech
47 min listen
Antibiotic Resistance Emergency – Paul Turner & Robert McBride, Co-founders of Felix Biotechnology – The Troubling Rise of Antibiotic Resistance, Finding Solutions to Fix the Problem: Paul Turner & Robert McBride, co-founders of Felix Biotechnology (felixbt.com), discuss the growing problem of antibiotic resistance and the new therapies on the horizon. In this podcast they’ll discuss: The ways in which targeted... by Finding Genius Podcast
34 min listen
Pfizer Faces Lawsuit for Covid Vaccine Lies by Radio Rothbard
20 min listen
Collaborating with officials to continue developments by Conversations in Healthcare
39 min listen
The humble leader: In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Steve Ferguson, Chief Executive Officer at Medix Biochemica. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology... by Molecule to Market: Inside the outsourcing space
59 min listen
Plant-Based Biologics With iBio's Randy Maddux by Business Of Biotech
51 min listen
S2 E6 | The Right Prescription for Healthcare Marketing by How Agencies Thrive
42 min listen

Discover this podcast and so much more

Bonus: Jeremy Levin

Bonus: Jeremy Levin

Description

Titles in the series (61)

More Episodes from First Rounders

Related podcast episodes